Category: Oncology/Hematology
Global Oncology/Hematology
-
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the eight major markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Cancer Vaccines Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... CAGR of 11.54% during the forecast period. The COVID-19 pandemic had an adverse effect on the global economy and healthcare system. Pharmaceuticals, medical gadgets, and biotechnological items were all affected by the worldwide lockdown. Research ... Read More
-
Global Radiation Oncology Market 2023-2027
... on the radiation oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact ... Read More
-
Global Kidney Cancer Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Kidney Cancer sales for 2023 through 2029. With Kidney Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Active Pharmaceutical Ingredients Market Size By Therapeutic Category (Oncology, Infectious Diseases, Anti-Diabetics, CNS & Anesthesia, Cardiovascular Diseases Biologics), By Synthesis (Chemical Based API, Biological API, Highly Potent API (HPAPI)), By Contract Outsourcing (CDMO, CMO), By Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032
... Application (Humans, Veterinary), By Drug (Prescription, OTC), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 - 2032 Global Active Pharmaceutical Ingredients Market is poised to grow significantly between 2023 and ... Read More
-
Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2023-2029
... of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc. LPI (LP Information)' newest research report, the “Follicular Lymphoma Drugs Industry Forecast” ... Read More
-
Global Checkpoint Inhibitors for Treating Cancer Market Growth 2023-2029
... and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and ... Read More
-
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2023-2029
... from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with ... Read More
-
Global In-Vitro Colorectal Cancer Screening Tests Market Growth (Status and Outlook) 2023-2029
... “In-Vitro Colorectal Cancer Screening Tests Industry Forecast” looks at past sales and reviews total world In-Vitro Colorectal Cancer Screening Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected In-Vitro ... Read More
-
Global Basal Cell Carcinoma Treatment Market - 2023-2030
... 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030). Basal cell carcinoma (BCC) is a type of skin cancer. Basal cells, a type of skin cell that creates new skin cells as ... Read More
-
In Vitro Diagnostics Market by Product and Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Infectious Disease), End User (Hospitals, Clinics) - Forecast to 2027
... to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%. The growing adoption of point-of-care devices and rapid tests for early disease diagnosis, and the rising government ... Read More
-
Global Cancer Minimal Residual Disease Testing Market Growth 2023-2029
... result means that disease was still detected after treatment. An MRD negative result means that no disease was detected after treatment. LPI (LP Information)' newest research report, the “Cancer Minimal Residual Disease Testing Industry Forecast” ... Read More
-
Global Checkpoint Inhibitor Refractory Cancer Market Growth (Status and Outlook) 2023-2029
... Cancer sales in 2022, providing a comprehensive analysis by region and market sector of projected Checkpoint Inhibitor Refractory Cancer sales for 2023 through 2029. With Checkpoint Inhibitor Refractory Cancer sales broken down by region, market ... Read More
-
Global Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic ... Read More
-
Global Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico, Germany, France, ... Read More
-
Global Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer ... Read More
-
Global Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65 and 65, and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Region (North America, Europe, ... Read More
-
Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, Solid Tumors, Others); By Test Technique; By End-User; By Region; Segment Forecast, 2023-2032
... is expected to reach USD 7,131.61 million by 2032, according to a new study by Polaris Market Research. The report “Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, ... Read More
-
Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032
... global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032. The growth in the ... Read More
-
Global Magnetic Resonance Imaging (MRI) Market Size study & Forecast, by Architecture (Closed MRI Systems, Open MRI Systems), by Field Strength (Low Field MRI Systems, High Field MRI Systems, Very High Field MRI Systems and Ultra-high MRI Systems), by Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, Other Applications) and Regional Analysis, 2022-2029
... Ultra-high MRI Systems), by Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, Other Applications) and Regional Analysis, 2022-2029 Global Magnetic Resonance Imaging (MRI) Market is valued at approximately USD 7.65 billion in 2021 and is anticipated to ... Read More
-
2023 Global Forecast for Cancer Gene Therapy (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales (product ... Read More
-
2023 Global Forecast for Breast Cancer Liquid Biopsy Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
Research Assistance
